Hypoxia‐inducible factor‐1α contributes to the proliferation of cholesteatoma keratinocytes through regulating endothelin converting enzyme 1 expression
Authors:
Open Access
- 23 March 2024
- journal article
- research article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (2) , e1233
Abstract
Objective: Cholesteatoma is a hyperproliferative, pseudoneoplastic lesion of the middle ear characterized by aggressive growth and bone destruction. Hypoxia‐inducible factor‐1α (HIF‐1α, also known as HIF1A) is a key transcription factor that enters the nucleus and upregulates many genes involved in cancer progression in the oxygen‐free environment. This study is designed to explore the role and mechanism of HIF1A in the progression of cholesteatoma.Methods: HIF1A and endothelin converting enzyme 1 (ECE1) levels were determined using real‐time quantitative polymerase chain reaction. The protein levels of HIF1A, Cyclin D1, proliferating cell nuclear antigen, and ECE1 were measured using western blot. Cell viability, proliferation, and cell cycle progression were analyzed using cell counting kit‐8, Colony formation, 5‐ethynyl‐2′‐deoxyuridine, and flow cytometry assays. Binding between HIF‐1α and ECE1 promoter was predicted by Jaspar and verified using Chromatin immunoprecipitation and dual‐luciferase reporter assays.Results: HIF1A and ECE1 were highly expressed in cholesteatoma patients and keratinocytes. Moreover, HIF1A knockdown might suppress the cell viability, proliferation, and cycle progression of cholesteatoma keratinocytes. Furthermore, HIF1A upregulated the transcription of ECE1 through binding to its promoter region.Conclusion: HIF1A might expedite cholesteatoma keratinocyte proliferation partly by increasing ECE1 expression, providing a possible therapeutic target for the cholesteatoma treatment.Keywords
This publication has 32 references indexed in Scilit:
- Etiopathogenesis of acquired cholesteatoma: Prominent theories and recent advances in biomolecular researchThe Laryngoscope, 2014
- Acquired cholesteatoma: summary of the cascade of molecular eventsThe Journal of Laryngology & Otology, 2013
- Integration of Oxygen Signaling at the Consensus HREScience's STKE, 2005
- [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].2005
- Expression of Hypoxia Inducible Factor 1 α and Von Hippel Lindau Protein in Human Middle Ear CholesteatomaThe Laryngoscope, 2003
- Regulation of Gene Expression by the Hypoxia-Inducible FactorsMolecular Interventions, 2002
- Hypoxia Regulation of Gene TranscriptionHigh Altitude Medicine & Biology, 2001
- Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.2000
- Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1αJournal of Cell Science, 1999
- Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1Journal of Biological Chemistry, 1996